sb 203580 has been researched along with lfm a13 in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (lfm a13) | Trials (lfm a13) | Recent Studies (post-2010) (lfm a13) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 24 | 0 | 10 |
| Protein | Taxonomy | sb 203580 (IC50) | lfm a13 (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase BTK | Mus musculus (house mouse) | 2.5 | |
| Tyrosine-protein kinase BTK | Homo sapiens (human) | 2.5 | |
| Serine/threonine-protein kinase PLK3 | Homo sapiens (human) | 7.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| Dart, ML; Hartnett, JR; Jost, E; Killoran, MP; Kirkland, TA; Machleidt, T; Robers, MB; Schwinn, MK; Shi, C; Wilkinson, JM; Wood, KV; Zimmerman, K | 1 |
2 other study(ies) available for sb 203580 and lfm a13
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Homogeneous Assay for Target Engagement Utilizing Bioluminescent Thermal Shift.
Topics: | 2018 |